Unichem Laboratories Limited (BOM: 506690)

Market Cap	40.33B
Revenue (ttm)	17.28B
Net Income (ttm)	-605.50M
Shares Out	70.41M
EPS (ttm)	-8.71
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Open	565.40
Previous Close	566.70
Day's Range	564.90 - 605.00
52-Week Range	394.85 - 631.05
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 21, 2024

About Unichem Laboratories

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944...

• Industry: Pharmaceutical Preparations
• Founded: 1944
• Employees: 2,875
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506690

Financial Performance

In 2023, Unichem Laboratories's revenue was 17.05 billion, an increase of 26.94% compared to the previous year's 13.43 billion. Losses were -704.74 million, -65.15% less than in 2022.